...
首页> 外文期刊>World journal of gastroenterology : >Risk of postoperative recurrence and postoperative management of Crohn's disease
【24h】

Risk of postoperative recurrence and postoperative management of Crohn's disease

机译:克罗恩病的术后复发风险和术后处理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Crohn's disease (CD) is a chronic inflammatory disease of the digestive tract with systemic manifestations. Etiology is unknown, even if immunological, genetic and environmental factors are involved. The majority of CD patients require surgery during their lifetime due to progressive bowel damage, but, even when all macroscopic lesions have been removed by surgery, the disease recurs in most cases. Postoperative management represents therefore a crucial mean for preventing recurrence. Several drugs and approaches have been proposed to achieve this aim. Endoscopic inspection of the ileocolic anastomosis within 1 year from surgery is widely encouraged, given that endoscopic recurrence is one of the greatest predictors for clinical recurrence. A strategy should be planned only after stratifying patients according to their individual risk of recurrence, avoiding unnecessary therapies when possible benefits are reduced, and selecting high-risk patients for more aggressive intervention.
机译:克罗恩病(CD)是具有全身性表现的消化道慢性炎症性疾病。即使涉及免疫,遗传和环境因素,病因也不明。大多数CD患者由于进行性肠损伤而需要终生手术,但是,即使通过手术切除了所有肉眼可见的病变,在大多数情况下该病仍会复发。因此,术后管理是预防复发的重要手段。已经提出了几种药物和方法来实现该目的。鉴于内镜复发是临床复发的最大预测指标之一,因此广泛鼓励在手术后1年内对内镜检查吻合口吻合术。仅在根据患者的复发风险对患者进行分层,在可能的获益减少时避免不必要的治疗以及选择高风险患者进行更积极的干预后,才应制定策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号